HER2 Support Group Forums - View Single Post - TDM1 Associate Marketing Director Position

schoonder · 04-08-2011, 06:23 AM

Roche reports the T-DM1 arm in its 1st-line HER2+ MBC phaseII trial had significantly longer progression free survival time, with less side effects than the Herceptin-Docetaxel arm.

http://www.morningstar.co.uk/uk/mark...38501957978184

04-08-2011, 06:23 AM	#4
schoonder Senior Member Join Date: Jul 2008 Posts: 186	Re: TDM1 Associate Marketing Director Position Roche reports the T-DM1 arm in its 1st-line HER2+ MBC phaseII trial had significantly longer progression free survival time, with less side effects than the Herceptin-Docetaxel arm. http://www.morningstar.co.uk/uk/mark...38501957978184